Background and objectives Lung cancer remains the leading cause of cancer-related mortality worldwide. Early detection of pulmonary nodules is crucial for timely diagnosis and effective treatment.

Cost-effectiveness analysis of population-based screening for 6-gene panel testing for hereditary breast and ovarian cancer. One-year impact of a large-scale pilot multimodal personalized early cancer ...

Innovative deep proteomic profiling reveals promising results from a blood-based test for early breast cancer, showcasing high sensitivity and specificity, explains Justin Drake, PhD. Current standard ...

The researchers measured the variation in DNA methylation patterns to develop the method and applied it to multiple types of cancer.

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer cases and 9.7 million cancer-related deaths globally in 2022, with ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...

Bangladeshi researcher Md Masum Billah is advancing the application of artificial intelligence in healthcare and digital security, focusing on practical solutions for real-world challenges, said a ...

Five artificial intelligence (AI) technologies designed to act as a "second pair of eyes" during colonoscopies have been conditionally recommended for NHS use by the National Institute for Health and ...

SpotitEarly, a biotech startup that uses AI and dogs to detect cancer using an at-home test, announced its launch into the U.S. market with $20.3 million in funding. The company has received funding ...